| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient.
|
Gastroenterology
|
2004
|
3.61
|
|
2
|
NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.
|
J Natl Compr Canc Netw
|
2007
|
3.40
|
|
3
|
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.
|
Lancet Oncol
|
2007
|
3.38
|
|
4
|
Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution.
|
Cancer
|
2006
|
2.98
|
|
5
|
Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment.
|
Ann Surg Oncol
|
2009
|
2.48
|
|
6
|
Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution.
|
Cancer
|
2004
|
2.46
|
|
7
|
Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution.
|
Cancer
|
2003
|
2.11
|
|
8
|
Imatinib mesylate in chordoma.
|
Cancer
|
2004
|
1.94
|
|
9
|
Phase II study of imatinib in advanced chordoma.
|
J Clin Oncol
|
2012
|
1.89
|
|
10
|
Chordoma.
|
Curr Opin Oncol
|
2007
|
1.75
|
|
11
|
Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.
|
Cancer Res
|
2010
|
1.68
|
|
12
|
Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan.
|
J Clin Oncol
|
2005
|
1.61
|
|
13
|
High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
|
Radiology
|
2009
|
1.53
|
|
14
|
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors.
|
Mol Cancer Ther
|
2009
|
1.52
|
|
15
|
Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
|
Cancer
|
2005
|
1.45
|
|
16
|
Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression.
|
Cancer Res
|
2006
|
1.44
|
|
17
|
Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.
|
Clin Cancer Res
|
2008
|
1.43
|
|
18
|
Thoracopleuropneumonectomy with riblike reconstruction for recurrent thoracic sarcomas.
|
Ann Surg Oncol
|
2014
|
1.40
|
|
19
|
Lack of SYT-SSX fusion transcripts in malignant peripheral nerve sheath tumors on RT-PCR analysis of 34 archival cases.
|
Lab Invest
|
2002
|
1.40
|
|
20
|
Response to sunitinib malate in advanced alveolar soft part sarcoma.
|
Clin Cancer Res
|
2009
|
1.39
|
|
21
|
Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
|
Clin Cancer Res
|
2006
|
1.35
|
|
22
|
Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate.
|
J Clin Oncol
|
2005
|
1.32
|
|
23
|
Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response.
|
Mol Cancer Ther
|
2010
|
1.29
|
|
24
|
Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control.
|
Ann Surg Oncol
|
2010
|
1.28
|
|
25
|
Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience.
|
Ann Surg Oncol
|
2013
|
1.28
|
|
26
|
Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
|
Ann Surg Oncol
|
2009
|
1.28
|
|
27
|
Aggressive fibromatosis in children and adolescents: the Italian experience.
|
Cancer
|
2010
|
1.27
|
|
28
|
Epithelioid sarcoma in children and adolescents: a report from the Italian Soft Tissue Sarcoma Committee.
|
Cancer
|
2006
|
1.27
|
|
29
|
Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
|
Cancer
|
2007
|
1.27
|
|
30
|
Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity.
|
Ann Surg Oncol
|
2006
|
1.27
|
|
31
|
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
|
Clin Cancer Res
|
2007
|
1.21
|
|
32
|
p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors.
|
Clin Cancer Res
|
2003
|
1.16
|
|
33
|
Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
|
Ann Surg Oncol
|
2012
|
1.16
|
|
34
|
The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.
|
Cancer
|
2008
|
1.15
|
|
35
|
CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
|
Cancer
|
2013
|
1.13
|
|
36
|
Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.
|
Am J Surg Pathol
|
2011
|
1.12
|
|
37
|
Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution.
|
Ann Surg Oncol
|
2007
|
1.11
|
|
38
|
High-grade sarcomatous overgrowth in solitary fibrous tumors: a clinicopathologic study of 10 cases.
|
Am J Surg Pathol
|
2012
|
1.11
|
|
39
|
Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava.
|
Ann Surg Oncol
|
2011
|
1.11
|
|
40
|
Myxofibrosarcoma: prognostic factors and survival in a series of patients treated at a single institution.
|
Ann Surg Oncol
|
2010
|
1.09
|
|
41
|
Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.
|
Clin Cancer Res
|
2004
|
1.08
|
|
42
|
Dermatofibrosarcoma protuberans-derived fibrosarcoma: clinical history, biological profile and sensitivity to imatinib.
|
Int J Cancer
|
2011
|
1.08
|
|
43
|
9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
|
Cancer
|
2005
|
1.07
|
|
44
|
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas.
|
Neuro Oncol
|
2010
|
1.04
|
|
45
|
PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor.
|
Neuro Oncol
|
2009
|
1.04
|
|
46
|
Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk.
|
Ann Surg
|
2014
|
1.03
|
|
47
|
Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management.
|
Expert Rev Anticancer Ther
|
2009
|
1.03
|
|
48
|
Carney triad: case report and molecular analysis of gastric tumor.
|
Hum Pathol
|
2005
|
1.01
|
|
49
|
c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.
|
Clin Cancer Res
|
2007
|
1.01
|
|
50
|
Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 33 patients at a single institution.
|
Ann Surg Oncol
|
2010
|
1.00
|
|
51
|
Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.
|
Cancer
|
2004
|
0.99
|
|
52
|
Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
|
Ann Surg Oncol
|
2010
|
0.98
|
|
53
|
Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body size.
|
J Clin Oncol
|
2008
|
0.97
|
|
54
|
Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought.
|
Ann Surg Oncol
|
2013
|
0.97
|
|
55
|
Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis.
|
BMC Cancer
|
2010
|
0.96
|
|
56
|
Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issues.
|
Semin Oncol
|
2009
|
0.95
|
|
57
|
Adult-type soft tissue sarcomas in paediatric age: a nomogram-based prognostic comparison with adult sarcoma.
|
Eur J Cancer
|
2007
|
0.94
|
|
58
|
Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy.
|
Cancer
|
2012
|
0.94
|
|
59
|
Desmoid-type fibromatosis: what works best?
|
Eur J Cancer
|
2009
|
0.93
|
|
60
|
Novel models of myxoid liposarcoma xenografts mimicking the biological and pharmacologic features of human tumors.
|
Clin Cancer Res
|
2010
|
0.93
|
|
61
|
Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib.
|
Clin Sarcoma Res
|
2013
|
0.91
|
|
62
|
Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study.
|
Clin Sarcoma Res
|
2013
|
0.91
|
|
63
|
Soft-tissue sarcomas of the extremities in patients of pediatric age.
|
J Child Orthop
|
2007
|
0.90
|
|
64
|
Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS).
|
Eur J Cancer
|
2009
|
0.89
|
|
65
|
Prognostic determinants in epithelioid sarcoma.
|
Eur J Cancer
|
2011
|
0.89
|
|
66
|
Prognostic factors and outcome of spermatic cord sarcoma.
|
Ann Surg Oncol
|
2014
|
0.89
|
|
67
|
Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib.
|
Clin Sarcoma Res
|
2012
|
0.89
|
|
68
|
Emerging therapies for adult soft tissue sarcoma.
|
Expert Rev Anticancer Ther
|
2014
|
0.88
|
|
69
|
Histology-specific nomogram for primary retroperitoneal soft tissue sarcoma.
|
Cancer
|
2010
|
0.88
|
|
70
|
Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG.
|
Ann Surg Oncol
|
2012
|
0.87
|
|
71
|
Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers.
|
Spine (Phila Pa 1976)
|
2016
|
0.87
|
|
72
|
Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.
|
Tumori
|
2002
|
0.86
|
|
73
|
Hyperthermia as an adjunctive treatment for soft-tissue sarcoma.
|
Expert Rev Anticancer Ther
|
2009
|
0.86
|
|
74
|
Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone.
|
Am J Surg Pathol
|
2003
|
0.86
|
|
75
|
High CD133 expression levels in gastrointestinal stromal tumors.
|
Cytometry B Clin Cytom
|
2011
|
0.83
|
|
76
|
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.
|
Am J Surg Pathol
|
2015
|
0.82
|
|
77
|
Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma.
|
Genes Chromosomes Cancer
|
2011
|
0.82
|
|
78
|
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?
|
Transl Oncol
|
2008
|
0.82
|
|
79
|
Activate and resist: L576P-KIT in GIST.
|
Mol Cancer Ther
|
2009
|
0.82
|
|
80
|
Advanced extremity soft tissue sarcoma: prognostic effect of isolated limb perfusion in a series of 88 patients treated at a single institution.
|
Ann Surg Oncol
|
2006
|
0.82
|
|
81
|
Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group.
|
Ann Surg
|
2017
|
0.82
|
|
82
|
Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma.
|
J Clin Oncol
|
2009
|
0.81
|
|
83
|
Localised thoracic sarcomas: outcome improvement over time at a single institution.
|
Eur J Cancer
|
2013
|
0.81
|
|
84
|
Adjuvant therapy of gastrointestinal stromal tumors (GIST).
|
Curr Treat Options Oncol
|
2012
|
0.81
|
|
85
|
Angiosarcoma of the breast and vascular endothelial growth factor receptor.
|
Tumori
|
2011
|
0.81
|
|
86
|
Quality of local treatment or biology of the tumor: which are the trump cards for loco-regional control of retroperitoneal sarcoma?
|
Ann Surg Oncol
|
2013
|
0.80
|
|
87
|
The combination of surgery and imatinib in GIST: a reality for localized tumors at high risk, an open issue for metastatic ones.
|
Ann Surg Oncol
|
2012
|
0.80
|
|
88
|
In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomas.
|
Lab Invest
|
2013
|
0.79
|
|
89
|
Surgery in retroperitoneal soft tissue sarcoma: a call for a consensus between Europe and North America.
|
Ann Surg Oncol
|
2011
|
0.79
|
|
90
|
Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in management.
|
Expert Rev Anticancer Ther
|
2012
|
0.79
|
|
91
|
Surgery in soft tissue sarcoma: more conservative in extremities, more extended in the retroperitoneum.
|
Expert Rev Anticancer Ther
|
2012
|
0.78
|
|
92
|
Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.
|
Neuro Oncol
|
2014
|
0.78
|
|
93
|
Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance.
|
Neuro Oncol
|
2012
|
0.78
|
|
94
|
MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study.
|
Mol Cancer Ther
|
2013
|
0.78
|
|
95
|
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma.
|
J Surg Oncol
|
2014
|
0.77
|
|
96
|
Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: an imaging, biochemical and molecular modeling study.
|
Int J Cancer
|
2011
|
0.77
|
|
97
|
Personalizing surgical margins in retroperitoneal sarcomas.
|
Expert Rev Anticancer Ther
|
2015
|
0.76
|
|
98
|
Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumors.
|
Oncologist
|
2013
|
0.75
|
|
99
|
Optimal approach to sporadic desmoid tumors: from radical surgery to observation. Time for a consensus?
|
Ann Surg Oncol
|
2012
|
0.75
|
|
100
|
ILP and RT: the study that will never be.
|
Ann Surg Oncol
|
2011
|
0.75
|
|
101
|
Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy.
|
J Transl Med
|
2011
|
0.75
|
|
102
|
Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
|
Cancer J
|
2017
|
0.75
|
|
103
|
Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease?
|
Cancer
|
2012
|
0.75
|
|
104
|
Cytoreductive surgery in advanced GIST: timing is everything.
|
Ann Surg Oncol
|
2013
|
0.75
|
|
105
|
Morbidity of left pancreatectomy when associated with multivisceral resection for abdominal mesenchymal neoplasms.
|
JOP
|
2011
|
0.75
|
|
106
|
Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents.
|
Med Oncol
|
2014
|
0.75
|
|
107
|
Fluorescence in situ hybridization analysis and immunophenotyping of c-Kit/PDGFRA and Bcl-2 expression in gastrointestinal stromal tumors.
|
Anal Quant Cytol Histol
|
2010
|
0.75
|
|
108
|
Neoadjuvant treatment: a novel standard?
|
Curr Opin Oncol
|
2017
|
0.75
|
|
109
|
Collaborations between SSO and the Connective Tissue Oncology Society (CTOS) series.
|
Ann Surg Oncol
|
2015
|
0.75
|